Impact of New-Onset Conduction Disturbances following Transcatheter Aortic Valve Replacement on Outcomes: A Single-Center Study

Table 2

Adverse events and outcomes.

	Overall (n = 337)	Persistent (n = 150)	Nonpersistent (n = 187)	values
30-day MACE	34 (10.1)	18 (12.0)	16 (8.6)	0.30
Death	10 (3.0)	6 (4.0)	4 (2.1)	0.35
Myocardial infarction	4 (1.2)	1 (0.7)	3 (1.6)	0.63
Stroke	7 (2.1)	3 (2.0)	4 (2.1)	1.00
Valve-related rehospitalization	11 (3.3)	6 (4.0)	5 (2.7)	0.55
Cardiac arrest	6 (1.8)	4 (2.7)	2 (1.1)	0.41
30-day adverse events
Coronary compression	1 (0.3)	0 (0.0)	1 (0.5)	1.00
Cardiac arrest	6 (1.8)	4 (2.7)	2 (1.1)	0.41
Major vascular complication	5 (1.5)	2 (1.3)	3 (1.6)	1.00
New conduction/native pacer disturbance requiring PPM	71 (21.1)	61 (40.7)	10 (5.3)	<0.001
1-year mortality
Cardiac-related mortality	21 (6.2)	14 (9.3)	7 (3.7)	0.035
All-cause mortality	40 (11.9)	24 (16.0)	16 (8.6)	0.036

Values are n (%). ICD = implantable cardioverter defibrillator; PPM = pacemaker.